Generic drugmakers face pricing pressure, but companies like TEVA, SDZNY and RDY are betting on complex generics and biosimilars to protect growth.
Source: https://www.zacks.com/commentary/2878485/3-generic-drug-stoc…
DAR, BP and PLAB made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 15th, 2026.
Durable growth is one of the key factors in finding stock multibaggers. MercadoLibre should continue to grow rapidly as it scales its e-commerce and fintech operations.
Chevron is a direct beneficiary of the disruption of Middle East oil and gas. ExxonMobil expects significant growth over the next few years that’s unrelated to the Iran war.
